| Financial Year |
March 31 2023 |
| Monetary Funds |
24,904,396,779.21 |
| Held-for-trading Financial Assets |
994,733,129.68 |
| Notes Receivable |
-- |
| Accounts Receivable |
9,285,469.39 |
| Advances to Suppliers |
149,186,102.82 |
| Other Receivables |
24,716,827.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,149,595,444.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
204,560,549.82 |
| Total Current Assets |
40,733,035,418.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,720,053,188.10 |
| Investment Properties |
38,808,444.86 |
| Fixed Assetes |
8,717,953,946.28 |
| Under-construction Projects |
1,022,552,627.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,076,898,287.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
491,790.36 |
| Deferred Income Tax Assets |
818,059,096.08 |
| Other Non-Current Assets |
196,593,102.48 |
| Sub-Total of Non-Current Assets |
17,608,380,985.21 |
| Total Assets |
58,341,416,403.54 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,260,191,342.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
402,461,910.95 |
| Taxes Payable |
2,154,561,840.04 |
| Interest Payable |
-- |
| Dividend Payable |
16,594,850.58 |
| Other payables |
1,271,331,621.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,818,118.11 |
| Other Current Liabilities |
224,349,548.80 |
| Sub-Total of Current Liabilities |
8,095,480,141.64 |
| Long-term Loans |
9,015,400,000.00 |
| Bonds Payable |
2,996,500,665.63 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
126,751,719.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,200,200,290.86 |
| Total Liabilities |
20,295,680,432.50 |
| Paid-In Capital(Or Share Stock) |
1,471,987,769.00 |
| Capital Surplus |
4,915,414,592.00 |
| Surplus Reserve |
1,471,895,100.00 |
| LESS:Treasury Stock |
647,312,723.52 |
| Undistributed Profits |
30,484,815,844.90 |
| Minority Stockholder's Interest |
131,025,922.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
37,914,710,048.73 |
| Owner's Equity（Stockholder's Equity） |
38,045,735,971.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
58,341,416,403.54 |
